Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Finnish legislation to separate device and pharma regulation

This article was originally published in RAJ Devices

Executive Summary

The Finnish president has submitted to parliament a bill that would separate the regulation of medicines and medical devices1. Passage of the legislation will make official the government’s earlier decision to transfer the regulation and market surveillance of devices from the National Agency for Medicines to the National Supervisory Authority for Welfare and Health (Valvira), located in Helsinki2.

You may also be interested in...



Finland updates device regulations in line with new law

Finland's National Supervisory Authority for Welfare and Health, Valvira, has issued four administrative orders regulating the procedures for medical device incident reporting, registration and clinical trials, in line with new medical devices legislation that came into force earlier this year1. The updated rules, which are expected to help manufacturers and other stakeholders better understand the various requirements, came into effect on 15 September.

Finland updates device regulations in line with new law

Finland's National Supervisory Authority for Welfare and Health, Valvira, has issued four administrative orders regulating the procedures for medical device incident reporting, registration and clinical trials, in line with new medical devices legislation that came into force earlier this year1. The updated rules, which are expected to help manufacturers and other stakeholders better understand the various requirements, came into effect on 15 September.

UsernamePublicRestriction

Register

SC092869

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel